• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[在降血脂药物研究中对各种实验性血脂蛋白异常模型的评价]

[Evaluation of various experimental dyslipoproteinemia models in the study of hypolipidemic agents].

作者信息

Ryzhenkov V E, Chistiakova A M, Frolova Iu V, Lozovskiĭ V T, Kameneva I Iu, Vasil'eva L E

出版信息

Patol Fiziol Eksp Ter. 1994 Oct-Dec(4):33-6.

PMID:7700697
Abstract

Models of experimental dyslipoproteinemias have been developed by using non-inbred rats (males and females) and guinea-pigs. Administration of cholesterol (C) with fats and supplementation of 4-hydroxy-6-methyl-2-thiouracil to male rats and that of C in the mixture of fats to guinea-pigs have been demonstrated to lead to the development of atherogenic dyslipoproteinemias. Genfibrozil, cholestyramine and vasosan II, a new pectin-enriched formulation, promoted normalization of the impaired serum lipoprotein spectrum caused by exogenous C administration. Bilateral ovariectomy in female rats induced atherogenic dyslipoproteinemia. The use of the estrogen derivative methyl ether of 6-oxa-D-homo-8-isoestrone normalized lipid and lipoprotein metabolic disturbances.

摘要

通过使用非近交系大鼠(雄性和雌性)和豚鼠建立了实验性血脂异常模型。已证明,给雄性大鼠喂食含脂肪的胆固醇(C)并补充4-羟基-6-甲基-2-硫尿嘧啶,以及给豚鼠喂食含C的脂肪混合物,会导致致动脉粥样硬化性血脂异常。吉非贝齐、考来烯胺和一种新的富含果胶的制剂Vasosan II,可促进外源性C给药引起的受损血清脂蛋白谱正常化。雌性大鼠双侧卵巢切除可诱发致动脉粥样硬化性血脂异常。使用雌激素衍生物6-氧杂-D-高-8-异雌酮甲醚可使脂质和脂蛋白代谢紊乱正常化。

相似文献

1
[Evaluation of various experimental dyslipoproteinemia models in the study of hypolipidemic agents].[在降血脂药物研究中对各种实验性血脂蛋白异常模型的评价]
Patol Fiziol Eksp Ter. 1994 Oct-Dec(4):33-6.
2
[The hypolipidemic action of water-soluble enterosorbents of cholesterol and bile acids in an experiment].[水溶性胆固醇和胆汁酸肠吸附剂在实验中的降血脂作用]
Eksp Klin Farmakol. 1992 Sep-Oct;55(5):41-4.
3
[The effect of the mineral composition of the diet on cholesterol metabolic indices and the experimental correction of propranolol-induced atherogenic dyslipoproteinemia].
Eksp Klin Farmakol. 1995 Jan-Feb;58(1):29-31.
4
[The hypolipidemic activity of natural substances].[天然物质的降血脂活性]
Eksp Klin Farmakol. 1992 Sep-Oct;55(5):44-7.
5
[Hypolipidemic activity of a water extract from roots carline thistle].[飞廉根水提取物的降血脂活性]
Vopr Pitan. 2005;74(4):31-2.
6
[Changes in the blood serum lipids and lipoproteins of rats in ovariectomy and to the administration of the methyl ester of 6-hydroxy-D-homo-8-isoestrone].[去卵巢大鼠及给予6-羟基-D-高-8-异雌酮甲酯后血清脂质和脂蛋白的变化]
Biull Eksp Biol Med. 1992 Jul;114(8):148-50.
7
[Lipanor treatment of atherogenic hyperlipoproteinemia].[利帕诺治疗致动脉粥样硬化性高脂蛋白血症]
Ter Arkh. 1998;70(9):57-61.
8
[The hypolipidemic and antiatherosclerotic action of absorbable and nonabsorbable substances in the intestines].[肠道中可吸收和不可吸收物质的降血脂及抗动脉粥样硬化作用]
Patol Fiziol Eksp Ter. 1989 Sep-Oct(5):16-9.
9
[Role of the patho-autokinetic element in the pathogenesis of disturbances of myocardial lipid composition induced by experimental atherogenic dyslipoproteinemia].[病理自身运动因素在实验性致动脉粥样硬化性血脂蛋白异常血症所致心肌脂质成分紊乱发病机制中的作用]
Patol Fiziol Eksp Ter. 1991 Sep-Oct(5):14-7.
10
[Pharmacological correction of lipid metabolism disturbances using new amide derivatives of taurine].[使用牛磺酸新酰胺衍生物对脂质代谢紊乱进行药理学纠正]
Eksp Klin Farmakol. 2007 Mar-Apr;70(2):48-50.